Real Estate & Construction » Real Estate | Beijing Centergate Technologies

Beijing Centergate Technologies | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
537
134
217
177
454
377
Total Accounts Receivable
1,934
540
736
876
1,075
1,221
Inventories
1,035
1,039
974
881
782
524
Other Current Assets
87
18
23
43
81
78
Total Current Assets
3,594
1,731
1,950
1,976
2,392
2,200
Net Property, Plant & Equipment
522
533
534
689
737
805
Total Investments and Advances
189
189
90
91
65
66
Intangible Assets
17
41
49
247
366
365
Other Assets
10
6
108
115
62
60
Total Assets
4,345
2,515
2,757
3,147
3,649
3,528
ST Debt & Current Portion LT Debt
552
398
608
587
558
Accounts Payable
1,531
360
393
276
388
Income Tax Payable
197
50
42
23
17
Other Current Liabilities
1,407
833
724
770
580
Total Current Liabilities
3,687
1,642
1,767
1,657
1,544
Long-Term Debt
-
-
100
316
229
Provision for Risks & Charges
-
12
2
2
2
Deferred Taxes
13
14
25
22
21
Other Liabilities
14
142
2
72
47
Total Liabilities
3,703
1,796
1,871
2,054
1,828
Common Equity (Total)
563
628
791
882
1,594
Total Shareholders' Equity
563
628
791
882
1,594
Total Equity
635
692
858
1,067
1,791
Liabilities & Shareholders' Equity
4,345
2,515
2,757
3,147
3,649
Accumulated Minority Interest
72
64
68
185
197
Non-Equity Reserves
7
26
27
26
30

About Beijing Centergate Technologies

View Profile
Address
Shenzhou Building
Beijing Beijing 100081
China
Employees -
Website http://www.centek.com.cn
Updated 07/08/2019
Beijing Centergate Technologies (Holding) Co., Ltd. engages in the development, management and investment of real estate. It operates business through four business segments-biomedical, personal care products, real estate & construction and other business. It mainly engages in the biomedical product preparation including tablets, injections, APIs, capsule, oral solution, granules, narcotic drugs, personal care products, manufacture and sale of commercial concrete and cement products.